Sort
1,049,261 grants matching “t cell”
In vivo targeting of diabetes-relevant human cell types with rAAV vectors
$3,604,708Markus Grompe · Oregon Health & Science University · UC4 · FY2014 · DK
New Mexico IDeA Networks of Biomedical Research Excellence (INBRE)
$3,604,509Shelley Lusetti · New Mexico State University Las Cruces · P20 · FY2017 · GM
Roles of Cholesterol and Membrane Nanodomains in the Amyloidogenic Pathway
$3,604,350Charles R Sanders · Vanderbilt University · RF1 · FY2017 · AG
Center for Human Immunology
$3,604,228James Cherry · National Institute Of Allergy And Infectious Diseases · ZIC · FY2024 · AI
Transplant Tolerance in Non-Human Primates
$3,604,011Christian P Larsen · Emory University · U19 · FY2015 · AI
Cancer Center Support (Core) Grant
$3,603,798Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2013 · CA
ERC Einstein-Rockefeller-CUNY Center for AIDS research
$3,603,724Harris Goldstein · Albert Einstein College Of Medicine · P30 · FY2022 · AI
UCCRC -Cancer Center Support Grant
$3,602,038University Of Chicago · P30 · FY2002 · CA
Cancer Center Support Grant
$3,601,591Dan Theodorescu · University Of Colorado Denver · P30 · FY2015 · CA
Nebraska Research Network in Functional Genomics
$3,601,586James B Turpen · University Of Nebraska Medical Center · P20 · FY2015 · GM
Comparative Functional Genomics INBRE in Maine
$3,601,458Patricia H. Hand · Mount Desert Island Biological Lab · P20 · FY2015 · GM
Emory-GA Tech Nanotechnology Center for Personalized an*
$3,600,018Shuming Nie · Emory University · U54 · FY2008 · CA
Specialized Center for the Protein Structure Initiative
$3,600,001University Of California San Francisco · U54 · FY2005 · GM
A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes
$3,600,000David A Rasko · University Of Maryland Baltimore · U19 · FY2019 · AI
The Bacterial and Viral Bioinformatics Resource Center (BV-BRC)
$3,600,000Rick L. Stevens · University Of Chicago · U24 · FY2024 · AI
Hampton-Brandeis Partnership for Research and Education in Materials
$3,600,000Demetris L Geddis · Hampton University · · FY2018 · MPS
Molecular Characterization of HIV-Associated Tumors by Sequencing
$3,600,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
THE PROJECT AIMS TO DEVELOP AND DELIVER HIGHLY DURABLE AND MANUFACTURABLE FUEL CELL MEAS WITH LOW-PGM NOVEL CATHODE CATALYST LOADING, ENHANCED MASS ACTIVITY AT HIGH OPERATIONAL POTENTIALS, IMPROVED HIGH CURRENT DENSITY PERFORMANCE, AND EXTENDED OPERATIONAL LONGEVITY AT A REDUCED COS. THE PROPOSED PROGRAM’S LEVEL OF PERFORMANCE WILL MEET THE M2FCT 2025 END-OF-LIFE MEA TARGET: DEMONSTRATION OF 2.5 KW/GPGM POWER OUTPUT (1.07 A/CM2 CURRENT DENSITY AT 0.7 V; 749 MW/CM2 AT 0.7 V) AFTER RUNNING A HEAVY-DUTY AST EQUIVALENT TO 25,000 HOURS. THE DEVELOPMENT OF COMMERCIALLY VIABLE PT-ALLOY CATALYSTS AND ANALYSIS TECHNIQUES FOR EVALUATING AND RANKING THEM AS PROPOSED HERE ARE BASED ON FUNDAMENTAL PRINCIPLES AND DISCOVERIES THAT WERE CONCEIVED IN OUR LABORATORIES. MITIGATION OF DEGRADATION PROCESSES IS FEASIBLE ONLY BY MATERIALS DESIGN AT ATOMIC/MOLECULAR LEVEL, WHICH IS A SIGNATURE OF THIS PROJECT. TO ENHANCE THE PERFORMANCE AND DURABILITY OF THE CATHODE CATALYST TO MEET THE MEDIUM- AND HEAVY-DUTY TARGETS WE WILL AIM TO: (1) DRIVE NANOSCALE SURFACE STRUCTURES TO MIMIC THAT OF PT(111)-SKIN, (2) INDUCE ORDERING IN THE ALLOY TO LIMIT TM LOSS , (3) INTRODUCE AU TO ENABLE SELF-HEALING, (4) OPTIMIZE THE INTERFACE BETWEEN WATER, IONOMER, AND THE CATALYST WITH MOLECULAR INTERFACIAL ADDITIVES, (5) DEPLOY NANOPARTICLES ON ADVANCED CARBON SUPPORTS WITH SELECTIVE ANCHORS, AND (5) INTEGRATE NOVEL MATERIALS IN TO HIGHLY DURABLE MEAS. THE TECHNICAL INNOVATIONS PROPOSED HERE RELY ON CUTTING EDGE FUNDAMENTAL DISCOVERIES AT ATOMIC/MOLECULAR SCALE THAT WILL BE APPLIED TO THE DEVELOPMENT OF NOVEL CATALYSTS FOR HIGHLY DURABLE SELF-HEALING MEAS. THE OUTCOME WILL BE GROUNDBREAKING MEA PERFORMANCE WHICH WILL MEET OR EXCEED THE M2FCT AND DOE TECHNICAL TARGET. THE FINAL DELIVERABLE OF THE PROJECT WILL BE AT LEAST 6 MEAS FOR INDEPENDENT TESTING BY THE M2FCT CORE LAB CONSORTIUM. THE DELIVERED MEAS WILL MEET/EXCEED THE M2FCT 2025 END-OF-LIFE TARGET.
$3,600,000University Of California Irvine · · FY2023 · Department of Energy
University of Pittsburgh MACS/WIHS CCS
$3,600,000Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · HL
Single-Cell Analyses of Human Islets in T1D Using Highly Multiplexed Imaging
$3,600,000Mark A Atkinson · University Of Florida · UC4 · FY2015 · DK
The Bacterial and Viral Bioinformatics Resource Center (BV-BRC)
$3,600,000Rick L. Stevens · University Of Chicago · U24 · FY2025 · AI
A Genomics Based Investigation of the Determinants of Polymicrobial Infectious Disease Outcomes
$3,600,000David A Rasko · University Of Maryland Baltimore · U19 · FY2020 · AI
IGERT: Stem Cell BIomanufacturing
$3,599,664Robert Nerem · Georgia Tech Research Corporation · · FY2010 · EDU
Advanced Imaging Core
$3,599,392Dennis Winkler · National Institute On Deafness And Other Communication Disorders · ZIC · FY2022 · DC
Infectious Diseases Research Technologies Core - RML
$3,599,299Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2013 · AI